πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8691848

Inhibitors of caspases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8686143

Compounds useful as inhibitors of Janus kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8686157

Processes for the facile synthesis of diaryl amines and analogues thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8674118

Compounds and methods for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8674108

Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8669081

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663936

Sodium channel protein type III Ξ±-subunit splice variant

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8664219

Aminopyrimidines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8664273

Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to trea

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658674

Thiophene analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8653103

Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-m

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8653088

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8642779

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637511

Aminopyrimidines useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637666

Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637457

Processes and intermediates

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8633189

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8633205

Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8633210

Triazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8629162

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8623905

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8623869

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8623894

Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-c

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8618106

Protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted